Skip to content
WELCOME10 — 10% OFF YOUR FIRST ORDER  ·  FREE SHIPPING OVER $300 CAD  ·  COA ON EVERY ORDER
Research Comparison

GLP-2/Tirz vs GLP-3/RT

GLP-2/Tirz and GLP-3/RT are studied in overlapping research areas, which is why they are frequently compared. This is a neutral side-by-side reference drawn from published preclinical literature and laboratory handling data.

Shared research areas:Metabolic
ClassLipidated dual receptor agonist (GIP / GLP-1), 39-residue chainLipidated single-chain triple receptor agonist (GIP / GLP-1 / glucagon)
Molecular weight4813.5 g/mol4759.5 g/mol
CAS numberNot assigned / not specifiedNot assigned / not specified
Purity spec≥99%≥99%
Research areasMetabolicMetabolic
Primary diluentBacteriostatic water (0.9% benzyl alcohol)Bacteriostatic water (0.9% benzyl alcohol)
Working windowCommonly worked with for 4–6 weeks at 2–8 °C.Commonly worked with for 4–6 weeks at 2–8 °C.
Lead degradation routeInterfacial aggregation from agitation or freezing — the dominant practical route.Interfacial aggregation from agitation, foaming, or freeze–thaw — the primary practical failure mode for this molecule class.
Freeze–thawDo not freeze reconstituted solution. Interfacial aggregation during freezing is the characteristic failure mode and is irreversible.Avoid freezing reconstituted material. For lipidated peptides the freeze–thaw risk is aggregation at the ice–liquid interface rather than chemical breakdown, and aggregation is not reversible on rewarming.
Light sensitivityNo specific light requirement beyond normal practice.No specific light requirement beyond normal practice.

How they actually differ

Comparing the two: GLP-2/Tirz is lipidated dual receptor agonist (gip / glp-1), 39-residue chain, while GLP-3/RT is lipidated single-chain triple receptor agonist (gip / glp-1 / glucagon) — different molecular classes with different handling consequences; their leading degradation routes differ (interfacial aggregation from agitation or freezing for GLP-2/Tirz, interfacial aggregation from agitation, foaming, or freeze–thaw for GLP-3/RT), so the storage precautions that matter are not the same. The sections below set out each in full.

GLP-2/Tirz — origin

GLP-2/Tirz is built on a GIP-based backbone rather than a GLP-1 one — an important and often-missed design detail. It was engineered from the GIP sequence and modified to acquire GLP-1 receptor activity, with a C20 fatty diacid attached via a linker for albumin binding. The term "twincretin" describes the dual incretin activity.

GLP-3/RT — origin

GLP-3/RT is a rationally engineered single peptide chain designed to activate three receptors at once — GIP, GLP-1, and glucagon. It represents the third generation of incretin design: mono-agonists first, dual agonists such as GLP-2/Tirz second, and triagonists third. Adding glucagon-receptor activity is the conceptual leap, since glucagon signalling contributes energy expenditure rather than only appetite and glycaemic effects.

GLP-2/Tirz research themes

Dual incretin engagement

Simultaneous GIP and GLP-1 receptor activity from a GIP-derived backbone.

Insulin secretion and glucagon suppression

Core metabolic research endpoints for the incretin class.

Gastric emptying

A well-characterised GLP-1 pathway effect studied in metabolic models.

GIP receptor pharmacology

Whether GIP agonism or antagonism is the productive direction remains an active research debate.

GLP-3/RT research themes

Triple receptor engagement

The defining feature: simultaneous GIP, GLP-1, and glucagon receptor activity from one chain.

Energy expenditure

Glucagon-receptor activity is studied for its contribution to energy expenditure, distinguishing triagonists from dual agonists.

Glucose regulation

Investigated in metabolic research models for effects on glucose homeostasis.

Body composition in research models

A major focus of the preclinical literature on this compound class.

GLP-2/Tirz handling

  • Swirl, never shake or vortex.
  • Add diluent down the vial wall and give the cake time — several minutes of slow dissolution is normal, not a defect.
  • Store upright and refrigerated; do not freeze once reconstituted.

GLP-3/RT handling

  • Never shake. Foam on a lipidated peptide solution is denatured material at the air–liquid interface, not a cosmetic issue.
  • Introduce diluent slowly down the vial wall and allow the cake to dissolve without agitation, which may take several minutes.
  • Do not freeze reconstituted solution — aggregation from freeze–thaw is irreversible.
  • Faint opalescence at high concentration is expected; visible particulate is not.

Both third-party tested

Every Popular Peptides batch of GLP-2/Tirz and GLP-3/RT is independently tested by HPLC and LC-MS with a published Certificate of Analysis. Enter a lot number to pull the COA for a specific vial.

Verify a batchPublished COAsHow we test

GLP-2/Tirz reference

Full GLP-2/Tirz reference GLP-2/Tirz storage GLP-2/Tirz reconstitution GLP-2/Tirz calculatorGLP-2/Tirz product details

GLP-3/RT reference

Full GLP-3/RT reference GLP-3/RT storage GLP-3/RT reconstitution GLP-3/RT calculatorGLP-3/RT product details

Related comparisons

5-Amino-1MQ vs GLP-2/Tirz5-Amino-1MQ vs GLP-3/RTCJC-1295 (No DAC) vs GLP-2/TirzCJC-1295 (No DAC) vs GLP-3/RTCJC-1295 + Ipamorelin vs GLP-2/TirzCJC-1295 + Ipamorelin vs GLP-3/RTGLP-2/Tirz vs IGF-1GLP-2/Tirz vs IGF-1 LR3

GLP-2/Tirz and GLP-3/RT are supplied strictly as research chemicals for in-vitro laboratory and research use only. They are not intended for human or animal consumption, diagnostic, or therapeutic use. This comparison summarizes published preclinical literature and laboratory handling data; it is not medical advice, not a claim of efficacy, and not usage guidance.